Atlas Trials

A Randomized, Double-blind, Placebo- and Active-controlled Study of the Electric Current Effects of ABT-639 on the Spontaneous Activity of Pain Sensory Receptors in Patients With Diabetic Peripheral Neuropathy

Clinical trial NCT01589432 · COMPLETED

Trial details

NCT number
NCT01589432
Sponsor
AbbVie (prior sponsor, Abbott)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetic Neuropathic Pain
Start date
2012-04-01
Primary completion
2012-11-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.